NCT05931952 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Andreasson KH, Skou ST, Ulrik CS, Madsen H, Sidenius K, Assing KD, Porsbjerg C, Bloch-Nielsen J, Thomas M, Bodtger U
Breathing Exercises for Patients with Asthma in Specialist Care: A Multicenter Randomized Clinical Trial. Ann Am Thorac Soc. 2022 Sep;19(9):1498-1506. doi: 10.1513/AnnalsATS.202111-1228OC.
Coulson E, Carpenter LM, Georgia TE, Baptist AP
Breathing exercises in older adults with asthma: a blinded, randomized, placebo-controlled trial. J Asthma. 2022 Jul;59(7):1438-1444. doi: 10.1080/02770903.2021.1936015. Epub 2021 Jun 14.
Das RR, Sankar J, Kabra SK
Role of Breathing Exercises in Asthma-Yoga and Pranayama. Indian J Pediatr. 2022 Feb;89(2):174-180. doi: 10.1007/s12098-021-03998-w. Epub 2021 Nov 23.
Stern J, Pier J, Litonjua AA
Asthma epidemiology and risk factors. Semin Immunopathol. 2020 Feb;42(1):5-15. doi: 10.1007/s00281-020-00785-1. Epub 2020 Feb 4.
Vagedes J, Helmert E, Kuderer S, Vagedes K, Wildhaber J, Andrasik F
The Buteyko breathing technique in children with asthma: a randomized controlled pilot study. Complement Ther Med. 2021 Jan;56:102582. doi: 10.1016/j.ctim.2020.102582. Epub 2020 Oct 23.

Comparative Effects Of Buteyko Breathing Techniques And Papworth Method On Pulmonary Functions And Oxygen Saturation In Asthmatic Patients

Clinical trial NCT05931952 - References